“This announcement demonstrates our unwavering commitment to developing a COVID-19 vaccine that is available to everyone on the market,” said Thomas Triomphe, executive vice president and global director of Sanofi Pasteur. “To address a global fitness crisis of this magnitude, partnerships are needed and we are grateful to Canada for its collaboration and with GSK for partnering with us to expand an effective vaccine.
Roger Connor, president of GSK Vaccines, added: “GSK is proud to work in partnership with Sanofi to make this vaccine as temporary as you can imagine in Canada. This announcement by the Government of Canada supports our ongoing efforts. “